BRPI0922920A2 - formas cristalinas de um composto de 3-carboxipropil-aminotetralina - Google Patents

formas cristalinas de um composto de 3-carboxipropil-aminotetralina

Info

Publication number
BRPI0922920A2
BRPI0922920A2 BRPI0922920A BRPI0922920A BRPI0922920A2 BR PI0922920 A2 BRPI0922920 A2 BR PI0922920A2 BR PI0922920 A BRPI0922920 A BR PI0922920A BR PI0922920 A BRPI0922920 A BR PI0922920A BR PI0922920 A2 BRPI0922920 A2 BR PI0922920A2
Authority
BR
Brazil
Prior art keywords
carboxypropyl
crystalline forms
aminotetraline
compound
aminotetraline compound
Prior art date
Application number
BRPI0922920A
Other languages
English (en)
Inventor
Rapta Miroslav
Dalziel Sean
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of BRPI0922920A2 publication Critical patent/BRPI0922920A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0922920A 2008-12-10 2009-12-09 formas cristalinas de um composto de 3-carboxipropil-aminotetralina BRPI0922920A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12125408P 2008-12-10 2008-12-10
PCT/US2009/067271 WO2010068649A1 (en) 2008-12-10 2009-12-09 Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Publications (1)

Publication Number Publication Date
BRPI0922920A2 true BRPI0922920A2 (pt) 2019-09-24

Family

ID=42122774

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922920A BRPI0922920A2 (pt) 2008-12-10 2009-12-09 formas cristalinas de um composto de 3-carboxipropil-aminotetralina

Country Status (21)

Country Link
US (4) US8101794B2 (pt)
EP (1) EP2376427B1 (pt)
JP (1) JP5650657B2 (pt)
KR (1) KR101685187B1 (pt)
CN (1) CN102245564B (pt)
AR (1) AR074592A1 (pt)
AU (1) AU2009324709B2 (pt)
BR (1) BRPI0922920A2 (pt)
CA (1) CA2745441C (pt)
CL (1) CL2011001391A1 (pt)
CO (1) CO6390054A2 (pt)
ES (1) ES2645087T3 (pt)
IL (1) IL213093A0 (pt)
MX (1) MX2011006209A (pt)
MY (1) MY179041A (pt)
NZ (1) NZ593377A (pt)
RU (1) RU2512390C2 (pt)
SG (1) SG172016A1 (pt)
TW (1) TWI449685B (pt)
WO (1) WO2010068649A1 (pt)
ZA (1) ZA201104319B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101791B2 (en) 2007-12-11 2012-01-24 Theravance, Inc. Aminotetralin compounds as mu opioid receptor antagonists
JP5403762B2 (ja) 2007-12-11 2014-01-29 セラヴァンス， インコーポレーテッド μオピオイド受容体アンタゴニストとしての３−カルボキシプロピル−アミノテトラリン誘導体
WO2011035142A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of opioid receptor antagonist for gastrointestinal tract disorders
US8658691B2 (en) * 2011-09-30 2014-02-25 Theravance, Inc. Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498196B1 (en) 1998-12-22 2002-12-24 Edward Roberts Compounds useful in pain management
US6844368B1 (en) 1998-12-22 2005-01-18 Edward Roberts Compounds useful in pain management
US6231594B1 (en) 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
AU2003241453A1 (en) * 2002-05-17 2003-12-02 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
MXPA05010821A (es) * 2003-04-08 2006-03-30 Progenics Pharm Inc Terapia de combinacion para constipacion que comprende un laxante y un antagonista opioide periferico.
SE0301794D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
WO2008057579A2 (en) 2006-11-07 2008-05-15 Nektar Therapeutics Al, Corporation Dosage forms and co-administration of an opioid agonist and an opioid antagonist
EP1997493A1 (en) * 2007-05-28 2008-12-03 Laboratorios del Dr. Esteve S.A. Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
US8101791B2 (en) 2007-12-11 2012-01-24 Theravance, Inc. Aminotetralin compounds as mu opioid receptor antagonists
JP5403762B2 (ja) 2007-12-11 2014-01-29 セラヴァンス， インコーポレーテッド μオピオイド受容体アンタゴニストとしての３−カルボキシプロピル−アミノテトラリン誘導体
ES2431354T3 (es) 2008-04-01 2013-11-26 Theravance, Inc. Derivados de 2-aminotetralina como antagonistas del receptor de opioide mu

Also Published As

Publication number Publication date
CO6390054A2 (es) 2012-02-29
TWI449685B (zh) 2014-08-21
WO2010068649A1 (en) 2010-06-17
CL2011001391A1 (es) 2011-11-11
MX2011006209A (es) 2011-07-12
US8101794B2 (en) 2012-01-24
SG172016A1 (en) 2011-07-28
US20120088834A1 (en) 2012-04-12
ES2645087T3 (es) 2017-12-04
US8486958B2 (en) 2013-07-16
NZ593377A (en) 2013-07-26
JP2012511580A (ja) 2012-05-24
US20130345466A1 (en) 2013-12-26
AR074592A1 (es) 2011-01-26
US8324236B2 (en) 2012-12-04
ZA201104319B (en) 2012-03-28
IL213093A0 (en) 2011-07-31
CA2745441C (en) 2017-10-17
US8969367B2 (en) 2015-03-03
AU2009324709B2 (en) 2015-07-16
RU2011128393A (ru) 2013-01-20
US20100144881A1 (en) 2010-06-10
CA2745441A1 (en) 2010-06-17
US20130065916A1 (en) 2013-03-14
CN102245564B (zh) 2015-04-01
AU2009324709A1 (en) 2011-06-30
TW201026646A (en) 2010-07-16
EP2376427A1 (en) 2011-10-19
CN102245564A (zh) 2011-11-16
RU2512390C2 (ru) 2014-04-10
JP5650657B2 (ja) 2015-01-07
KR20110093938A (ko) 2011-08-18
KR101685187B1 (ko) 2016-12-09
MY179041A (en) 2020-10-26
EP2376427B1 (en) 2017-08-02

Similar Documents

Publication Publication Date Title
DK2262793T3 (da) Krystallinske former af nilotinib-hci
CY2017026I2 (el) Τετρακυκλικη ενωση
CY2019011I2 (el) C7-φθορο υποκατεστημενες ενωσεις τετρακυκλινης
BRPI0911254A2 (pt) processo para a preparação de um composto
BR112012000890A2 (pt) formas de base livre cristalina de um composto bifenil
BRPI0912778A2 (pt) composto de amida
DK1856050T3 (da) Krystallinske former af en biphenylforbindelse
BR112012006686A2 (pt) composto amida substituído
DK2662352T3 (da) Fremgangsmåde til fremstilling af phenylacetamidforbindelse
BRPI0906186A2 (pt) composto e uso de um composto
DK1874766T3 (da) Krystallinsk form af en quinolinon-carboxamid-forbindelse
BRPI0906098A2 (pt) Método de preparação de um composto
BRPI0812630A2 (pt) de compostos funcionais a um substrato
BRPI1013868A2 (pt) composto diaciletilenodiamina
BRPI0814801A2 (pt) composto de piridazina cristalina
BRPI1007017A2 (pt) uso de um composto.
BRPI0922464A2 (pt) Combinações de compostos ativos
BRPI0918602A2 (pt) composto (i)
BRPI0815332A2 (pt) Composto de ácido fenilacético
BRPI0923592A2 (pt) composto
BRPI0911393A2 (pt) composto de 5-hidroxipirimidina-4-carboxamida
DK2143429T5 (da) Anvendelse af cilastatin til reduktion af nephrotoksicitet af forskellige forbindelser
BRPI0922920A2 (pt) formas cristalinas de um composto de 3-carboxipropil-aminotetralina
BRPI0909461A2 (pt) Composto de enaminotiocarbonila substituídos
BRPI0917412A2 (pt) composto e uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: THERAVANCE BIOPHARMA RANDD IP, LLC (US)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.